The Pharmacist

AUGUST 3, 2023

The total full-time equivalent (FTE) community pharmacy workforce has fallen by 6% in a year period, despite the overall number of pharmacists remaining ‘almost constant’, latest results from NHS England’s Community Workforce Survey 2022 has shown. Vacancy rates among pharmacists are up 16%, with indications that locum pharmacists are being used more and working fewer […] The post Total community pharmacy workforce drops 6% in a year appeared first on The Pharmacist.

Community Pharmacies 93

Community Pharmacies 93

STAT

AUGUST 3, 2023

New research that combines technology to sequence “ancient DNA” with direct-to-consumer genetic testing has identified tens of thousands people alive today who are genetically linked to enslaved and free African Americans who worked at a once-thriving Maryland iron forge in the late 18th and early 19th century. The findings, reported Thursday in Science , are a step toward restoring difficult-to-obtain ancestry knowledge to African Americans who descended from enslaved people, whos

246

246

PharmaVoice

AUGUST 3, 2023

A smaller player in the Alzheimer’s space, Prothena is approaching the next phase of treatments, including prevention and clinical trial evolution.

246

246

The Thyroid Pharmacist

AUGUST 4, 2023

You may have heard of the term “MTHFR gene mutation” and may be wondering what it is. First, I’d like to say that I prefer the term “MTHFR gene variation” rather than “mutation.” The word mutation makes it sound like there’s something wrong with the person, while variation is more empowering – and in my opinion, also more accurate. While the word “mutation” implies an occurrence that is rare, unnatural, or flawed, the MTHFR gene variation is common.

Insurance Coverage and Processing 105

Insurance Coverage and Processing Immunity Immunization Dosage 105

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

Pharma Times

AUGUST 2, 2023

The University of Strathclyde, the NHS and New York University join forces to increase knowledge - News - PharmaTimes

117

117

STAT

AUGUST 3, 2023

Patients are bracing for “D-Day,” the date their insurance companies will stop covering the drugs. Doctors are getting letters from insurance investigators discouraging new prescriptions. And pharmacies are being told by insurers to check for a specific diagnosis when filling prescriptions. It’s a charge on all fronts by insurance companies to contain the spiraling costs of a new class of weight loss-inducing drugs, the GLP-1s.

Diabetes 246

Diabetes 246

BioPharma Dive

JULY 31, 2023

According to the company, FDA officials have signaled openness to using a surrogate endpoint for assessing accelerated approval of a treatment for limb-girdle muscular dystrophy.

98

98

European Pharmaceutical Review

AUGUST 4, 2023

A new study published in The Lancet HIV has demonstrated the safety and efficacy of a new dispersible drug formulation of an immediate-release tablet as a human immunodeficiency virus (HIV) treatment for children. The single fixed dose combination (FDC) contains dolutegravir , abacavir and lamivudine. “This is the first FDC containing dolutegravir that can be used for children from 13 to 88 pounds,” explained Kristina Brooks, PharmD, an Assistant Professor in the University of Colorado Skaggs Sc

98

98

STAT

AUGUST 3, 2023

WASHINGTON — An already record-setting summer heat wave will continue through August and will put more than 51 million Americans at risk of health impacts, according to new data from federal health officials. Most of those vulnerable people live in 26 states and are expected to have at least five extreme heat days this month. Among the highest-risk counties, roughly 45% have high levels of uninsured adults and children and 18% have high senior populations, according to a relatively new mo

246

246

PharmaVoice

AUGUST 4, 2023

From Congress to the FTC to state legislatures, regulators are cracking the whip against PBMs.

242

242

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

BioPharma Dive

AUGUST 3, 2023

One patient received its Duchenne gene therapy, Elevidys, this week and a handful more could follow shortly, surprising some analysts and raising near-term sales expectations.

98

98

European Pharmaceutical Review

AUGUST 3, 2023

The Danish Medicines Agency (Lægemiddelstyrelsen) has announced the European Pharmacopoeia Commission has adopted a new European monograph, which describes quality requirements for the raw material Cannabis flower. EPC’s new Cannabis flower monograph The new monograph Cannabis flower (Cannabis flower, monograph 3028) will be available next year in January 2024 with publication of the supplement 11.5.

Compounding 98

Compounding Pharmaceutical Companies Pharmaceutical Companies 98

STAT

AUGUST 2, 2023

Simon Matthews made three trips this spring to the emergency room of his local hospital in Eastbourne, on England’s southeast coast, before doctors managed to figure out what was making him so ill. He had a fever of 104 Fahrenheit, uncommonly high for an adult. On his first foray to the hospital — in an ambulance — it was feared he had meningitis.

Hospitals 246

Hospitals 246

PharmaVoice

AUGUST 3, 2023

Pfizer’s recent earnings report could foretell major trouble in the market for pandemic products.

228

228

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

Digital Pharmacist

JULY 31, 2023

To boost your pharmacy’s storefront sales, the best place to start is by understanding the importance of pharmacy marketing and making sure you are taking the necessary steps to optimize your front-end sales. With the right strategies, you can increase customer loyalty, drive more sales, and establish yourself as a reliable pharmacy in your community.

Patient Counseling 98

Patient Counseling Communication Pharmacy Management 98

European Pharmaceutical Review

AUGUST 2, 2023

A new COVID-19 vaccine has been authorised by the Medicines and Healthcare products Regulatory Agency (MHRA). Bimervax is now the ninth vaccine to be authorised by the UK’s independent medicines regulator to treat the virus. MHRA authorisation of Bimervax The COVID-19 vaccine, developed by HIPRA Human Health, combines a part of the SARS-CoV-2 virus spike protein with an adjuvant, according to the MHRA.

Vaccines 98

Vaccines Immunization Immunity 98

STAT

AUGUST 1, 2023

The U.S. Department of Labor claims in a new lawsuit that a UnitedHealth Group unit illegally rejected emergency room care and urine drug screen claims for thousands of people. UMR, Inc., a Wisconsin-based third-party administrator owned by UnitedHealth, manages benefits for more than 2,100 employee health plans. The federal government says the company denied ER visits and urine drug screens for years using a process that didn’t meet federal standards for health plans that employers fund

Hospitals 246

Hospitals 246

Med Ed 101

JULY 30, 2023

After my recent post on my top 5 medication/vitamin interactions, I received the request to cover medications that deplete vitamins and minerals. I loved this idea because it is an important consideration in clinical practice! Keep in mind that these often show up on pharmacology and board exams as well! Without further ado, here are […] The post Medications That Deplete Vitamins And Minerals – Top 10 appeared first on Med Ed 101.

98

98

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

PharmExec

JULY 31, 2023

Rebekah Martin, senior VP of reward, inclusion, and talent acquisition at AstraZeneca, discusses ways to address the need for talent in pharma, how pharma can increase more interest in young talent, and how many roles in pharma will require a degree in the coming years in this Pharmaceutical Executive Podcast video.

98

98

European Pharmaceutical Review

AUGUST 2, 2023

Research published in Biotechnology and Bioengineering has demonstrated two innovative, automatic, online, real-time sample acquisition and preparation systems for in-process monitoring, control, and release of biopharmaceuticals. The proposed autonomous process analytical technology (PAT) platform comprises of a micro sequential injection (µSI) process analyser and automatic assay preparation platform (A2P2) for use in the laboratory as an off-line analytical system and on the manufacturing flo

98

98

STAT

AUGUST 1, 2023

For what would have been Henrietta Lacks’s 103th birthday, her family got her some justice: A settlement with Thermo Fisher Scientific over the Massachusetts-based company’s use of cells obtained without her consent seven decades ago. The story of Lacks, a Black woman whose cells have contributed to scientific breakthroughs ranging from the development of polio and cancer treatments to the mapping of the human genome, is one of the best-known tales of the exploitation of marginaliz

246

246

FDA Law Blog: Biosimilars

JULY 31, 2023

By Larry K. Houck — President Barack Obama signed the Comprehensive Addiction and Recovery Act of 2016 (“CARA”) intended to reverse serious prescription drug abuse trend in the United States on July 22, 2016. CARA amended the Controlled Substances Act (“CSA”) to enable physicians or patients to request pharmacists to partially fill prescriptions for schedule II substances including opioids and to allow remaining quantities to be filled up to 30 days after issuance of the prescription (up to 72

Controlled Substances 98

Controlled Substances Long-Term Care Facilities Dosage Communication 98

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

Pharmaceutical Business Review

AUGUST 1, 2023

The drug-device combination product, Breyna is claimed to be the first US Food and Drug Administration (FDA)-approved generic version of AstraZeneca’s Symbicort. It will be immediately available in 160 mcg/4.5 mcg and 80 mcg/4.5 mcg doses. The therapy is indicated for the treatment of asthma patients aged six years and above. It is also indicated as the maintenance treatment of airflow obstruction and to reduce exacerbations in COPD patients, including chronic bronchitis and/or emphysema.

98

98

European Pharmaceutical Review

AUGUST 1, 2023

The only immuno- oncology treatment approved as frontline therapy for mismatch repair deficient (dMMR) or microsatellite instability-high (MSI-H), primary advanced or recurrent endometrial cancer in combination with chemotherapy, is now authorised in the US. Jemperli (dostarlimab), a programmed death receptor-1 (PD-1)-blocking antibody, has been approved by the US Food and Drug Administration (FDA).

Chemotherapy 98

Chemotherapy 98

STAT

AUGUST 3, 2023

The early warning disease network that alerted the world to the original SARS outbreak and the start of the Covid-19 pandemic appears to be in peril. A number of the senior moderators of ProMED-mail, a program operated by the International Society of Infectious Diseases, posted a letter of protest early Thursday, challenging a recently revealed plan to charge for subscriptions to the service.

246

246

Express Pharma

AUGUST 2, 2023

How do you see the global digital health scenario evolving in India, given the vulnerability of our health data, yet the promise of health insights to drive better health outcomes? Digital Health is now being used at different levels in the value chain and across the continuum of care. For seeking healthcare-related information, seven out of 10 people will search the internet, similarly for medical information.

Hospitals 98

Hospitals Nursing Homes Documentation 98

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Community Pharmacy

JULY 31, 2023

Summer is an ideal time to travel, and no matter where you are going, packing the medication you need is essential to enjoying your break from routine. Before you hit the road though, it’s worth taking the time to ensure your prescriptions are prepared to make the journey with you. Whether you have a specific condition that requires daily support or just want to be prepared in case of an emergency, a solid travel medication strategy helps protect not just your health but peace of mind.

Community Pharmacies 96

Community Pharmacies Documentation Labelling 96

European Pharmaceutical Review

AUGUST 1, 2023

Arvinas, Inc. and Pfizer Inc. have been awarded an Innovation Passport for vepdegestrant (ARV-471), an investigational PROTAC ® ER degrader, as a treatment for oestrogen receptor (ER)+/ human epidermal growth factor receptor (HER)2- locally-advanced breast cancer or metastatic breast cancer. The award was jointly granted by the UK Innovative Licensing and Access Pathway Steering Group, which consists of the All Wales Therapeutics and Toxicology Centre (AWTTC), the Medicines and Healthcare produc

98

98

STAT

JULY 31, 2023

WASHINGTON — The U.S. Preventive Services Task Force will discuss recommending Covid-19 screening, the first step in requiring insurers to permanently cover the tests at no cost to patients. The national panel of experts will convene and “determine whether and how Covid-19 screening might be considered within the Task Force’s scope,” chair Michael Barry wrote in a letter to Sen.

246

246

PharmaTech

AUGUST 1, 2023

AstraZeneca, via its subsidiary Alexion Pharmaceuticals, will purchase a portfolio of preclinical rare disease gene therapies from Pfizer in a deal worth up to $1 billion.

96

96

Express Pharma

AUGUST 1, 2023

The loss of exclusivity of AbbVie’s Humira (adalimumab) has become a perfect scenario to test if the Biologics Price Competition and Innovation (BPCI) act in the US can achieve the intention of the law. The potential revenue replacing Humira has resulted in many adalimumab biosimilar offerings being brought forth (currently nine FDA-approved agents), and a rapidly overcrowded market.

Biosimilars 98

Biosimilars 98